Age-based diseases of cognitive dysfunction such as dementia and Alzheimer’s are a growing problem in Canada that already cost the healthcare system over $10 billion annually. The ability to provide the general public with ubiquitous access to iterative cognitive function testing would be extremely valuable to the individual, society, and science. LRDG has commenced development […]
Read More